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Summary The presence of succinyl-coenzyme A: acetoacetate CoA-transferase (3-oxo acid-CoA transferase),
an initiator of ketone body utilization in non-hepatic tissue was examined in a number of animal and human
tumours of peripheral tissues. While enzyme levels in heart, kidney, lymphocytes and bladder were high, the
tumours contained low or non-detectable levels of transferase activity, comparable with that of normal liver.
The activities of acetoacetyl-CoA thiolase paralleled that of the transferase, except for the high activity in
liver, and in all cases the tumour content of the enzyme was lower than that of the brain. The activity of
3-hydroxybutyrate dehydrogenase was similar in both normal and tumour tissue. The results indicate that
tumours of non-hepatic tissues may be unable to metabolize ketone-bodies and suggest a therapeutic strategy
for selective starvation ofthe tumour by dietary modification.
Hyperlipemia associated with mobilization of free
fatty acids (FFA) from adipose tissue is a frequent
companion of neoplastic diseases (Muller &
Watkin, 1961). In certain cases the increased
mobilization of FFA is probably due to a lipolytic
factor (toxohormone L) produced by the tumour
tissue (Masuno et al., 1981). Despite the
hyperlipemia ketonuria is an uncommon
phenomenon in cancer cachexia (Mider, 1951;
Conyers et al., 1979). In starved tumour-bearing
animals ketonemia is less than in controls and the
utilization of ketone bodies by peripheral tissues of
tumour-bearing rats tends to be higher than in
tissues from controls (Mider, 1951).
Utilization of acetoacetate as an energy source
requires the presence of two enzymes succinyl-
coenzyme A: acetoacetate CoA-transferase (3 oxo
acid-CoA transferase) (EC 2.8.3.5) and 3 oxoacyl-
CoA thiolase (EC 2.3.1.9). The former enzyme is
essentially absent from normal liver, but is present
in peripheral tissues in varying amounts (Fenselau
& Wallis, 1974; Williamson et al., 1971). In contrast
to normal liver considerable amounts of 3-oxo acid
CoA-transferase are present in neonatal liver and in
hepatomas, with the increased activity correlating
with an increased growth rate (Fenselau & Wallis,
1973; Fenselau et al., 1975). Such an enzyme shift
could provide a metabolic advantage for the
tumour. The tumour content of the enzyme
required for the conversion of 3-hydroxybutyrate to
acetoacetate, 3-hydroxybutyrate dehydrogenase
(EC 1.1.1.30), however, has been found to decrease
with increasing tumour growth rate, implying a
possible limitation in tumour capacity for
utilization of ketone bodies (Ohe et al., 1967). The
activity of 3-hydroxybutyrate dehydrogenase in
renal tumours has been found to be considerably
reduced in comparison with normal kidney whilst
the levels of 3-oxo acid-CoA transferase and 3-
oxoacyl-CoA thiolase in renal tumours were similar
to that found in kidney (Williamson et al., 1970).
However, astrocytomas, glioblastoma multiforme,
Schwannomas and craniopharyngiomas have been
shown to contain considerably reduced 3 oxo acid-
CoA transferase activity when compared with
normal brain (Fredericks & Ramsey, 1978). The
present study is designed to expand the knowledge
on ketone body metabolism in tumour cells and
reports the activities of 3 oxo acid-CoA transferase,
acetoacetyl-CoA thiolase and 3-hydroxybutyrate
dehydrogenase in a number of extra-hepatic animal
and human tumours.
Materials and methods
Acetoacetyl-CoA, succinyl-CoA, acetoacetate
(lithium salt), sodium succinate, CoA and
nicotinamide-adenine dinucleotides were purchased
from Sigma Chemical Co. (Dorset) and were of the
highest available purity. 3-Hydroxybutyrate
dehydrogenase was obtained from Boehringer
Corp. (London) Ltd.
Tumours.
The transplantable animal tumours used in this
study were the PC6 plasmacytoma transplanted i.p.
into Balb/c mice, P388 murine lymphocytic
leukaemia and L1210 murine lymphocytic
leukaemia transplanted i.p. into BDF1 mice, M5076
murine reticulum cell sarcoma transplanted s.c. into
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BDF1 mice and the TLX5 lymphoma passaged i.p.
in CBA/CA mice. Other tumours were maintained
in tissue culture in Dulbecco's modified Eagles
medium containing 10% foetal calf serum under an
atmosphere of 10% CO2 in air. These were Walker
rat carcinoma 256 (W.256), a mouse bladder
carcinoma (MB), a human bladder carcinoma (EJ),
a rat tumour (RT112) and a human
erythroleukaemic cell line (K562) originating from
the pleural effusion of a patient with CML in blast
crisis (Lozzio & Lozzio, 1973). L132, a normal
human embryonic lung epithelial cell line was
purchased from GIBCO Europe.
Preparation oftissue extracts
Tissues from non-tumour bearing mice or tumours
freed of connective tissue were quickly weighed,
minced finely and transferred to a Potter-Elvehjem
all glass homogenizer. Homogenization was carried
out at 40C in 4 vol. of ice cold 0.25M sucrose in
1 mM 2-mercaptoethanol, 10mM Tris-HCl buffer,
pH 7.4. A portion of the homogenate cooled in ice-
water was exposed to ultrasonic vibration for 30sec
using an MSE sonic oscillator and 100 watts of
power. The sonically treated homogenates were
then centrifuged for 20min at 30,000g. The
supernatant fluid contained 100% of the 3-oxo acid
CoA transferase activity, 77% of the acetoacetyl
CoA thiolase activity and 200% of the 3-
hydroxybutyrate dehydrogenase activity. Enzyme
activity is expressed in terms of soluble protein.
Determination ofenzyme activities
The rate of acetoacetyl-CoA formation from
succinyl-CoA and acetoacetate was determined
spectrophotometrically at 313nm using a millimolar
extinction coefficient of 12cm-I (Williamson et al.,
1971). The cuvettes contained 50mM Tris-HCl, pH
8.5, 5mMMgCl2, 5mM iodoacetamide (to inhibit
acetoacetyl-CoA thiolase) 0.1 mM succinyl-CoA
and enzyme sample (up to 200MI for tumour tissue)
in a final volume of 2ml. The reaction was initiated
by the addition of acetoacetate (100 imol) and the
rate of increase in absorbance was measured at
250C for 2min. The reaction rate was calculated
from the linear portion of the absorption curve.
For determination of the rate of succinyl-CoA
formation the reaction mixture contained in a final
volume of 2ml, 50mM Tris-HCl, pH 8.5, 10mM
MgCl2, 5mM iodoacetamide and 0.1 mM
acetoacetyl-CoA at 250C. The change in absorbance
at 303 nm was recorded for 2min (spontaneous
hydrolysis of acetoacetyl-CoA) and then the
enzyme sample (up to 50pl) was added and AE303
was recorded for a further 3min. This represents
spontaneous hydrolysis plus acetoacetyl-CoA
deacylase activity. Sodium succinate (100,mol) was
added and 303 was recorded for a further 3min,
representing spontaneous hydrolysis plus deacylase
plus 3-oxoacid CoA-transferase activity. The
millimolar extinction coefficient of acetoacetyl-CoA
was taken as 20.5cm- 1 under these conditions
(Fenselau & Wallis, 1974).
The activity of acetoacetyl-CoA thiolase was
determined by measuring the decrease in E303 due
to cleavage of acetoacetyl-CoA (Stern et al., 1956).
The cuvettes contained 50mM Tris-HCl, pH 8.5,
5mM MgCl2, 75yM acetoacetyl-CoA, 100pM
CoA and 50mM KCI in a final volume of 2ml.
The reaction was initiated by the addition of the
sample (5-50pl) and the decrease in E303 was
recorded for 2min. The disappearance of
acetoacetyl-CoA was considered to be mainly due
to thiolase activity since the activities of interfering
enzymes in extra-hepatic tissues have been reported
to be negligible in comparison with that of the
thiolase (McGarry & Foster, 1969).
3-Hydroxybutyrate dehydrogenase activity was
determined by the increase in absorption at 340nm
due to the formation of NADH (Williamson et al.,
1971). The reaction cuvette contained 16mM Tris-
HCI, pH 8.5, 0.32mM hydrazine hydrate (brought
to pH 8.5 with INHCl) 16mM DL-3-
hydroxybutyrate and 0.45mM NAD in a total
volume of 3ml. The reaction was initiated by the
addition of the enzyme sample (50 or 100,pl) and
the increase in E340 was recorded for 60min. The
reaction rate was calculated from the linear part of
the absorption curve (generally over the first
20min). Activity of all enzymes is expressed in pM
of substrate utilized per minute per milligram of
cell protein. The protein content of the sample was
determined by Lowry's method using bovine serum
albumin as a standard.
The concentration of 3-hydroxybutyrate in the
experiment described in Table IV was determined by
the increase in absorbance at 340nm due to the
formation of NADH in the presence of 3-
hydroxybutyrate dehydrogenase as described by
Williamson et al. (1962).
Results
Activity of 3-hydroxybutyrate dehydrogenase in
mouse tissues
The activity of 3-hydroxybutyrate dehydrogenase
was of the same order ofmagnitude in both normal
and tumour tissues examined (Table I), suggesting
that the level of this enzyme in tumours is sufficient
to allow for utilization of 3-hydroxybutyrate by
metabolic oxidation.ACETOACETATE COENZYME A TRANSFERASE IN TUMOURS 295
Table I Activity of 3-hydroxybutyrate dehydrogenase
Relative
activity
Activity umolmin 1 mg1 (% ofheart)
Tissue protein +s.e. (n=3) value
Normal
Heart 8.5+0.5 100
Intestine 4.7+0.4 55
Liver 3.0+0.1 35
Kidney 2.0+0.2 23
Bladder 1.9+0.2 23
Brain 1.3+0.2 15
Lymphocytes 1.3+0.2 15
L132 1.3+0.2 15
hmours
K562 7.5+0.4 88
W256 5.0+0.8 59
EJ 4.5+0.5 53
RT 112 4.0+0.15 47
P388 2.3+0.2 27
TLX5 2.3+0.2 27
L1210 2.3+0.2 27
PC6 2.1±0.4 25
M5076 2.1+0.2 25
MB 0.4+0.1 15
Activity
tissues
of 3-oxo acid-CoA transferase in mouse
Among the normal mouse tissues examined the
level of 3-oxo acid-CoA transferase aetivity was
highest in the heart and lowest in the liver, with the
values for brain, lymphocytes and intestine falling
between these values (Table II). A similar
distribution of enzyme activity has been reported in
normal adult rat tissues (Mider, 1951, Fenselau &
Wallis, 1974). Using these normal mouse tissues as
a comparison, the level of the enzyme (measured in
the direction of acetoacetyl-CoA formation) in
tumours varied from 5% of the heart value in the
M5076 murine reticulum cell sarcoma to 0.1% of
the heart value in a human leukaemia cell line
(K562). These results suggest that 3-oxo acid-CoA
transferase activity is essentially absent from all of
the murine and human tumour lines that were
investigated.
The loss of 3-oxo acid-CoA transferase in the
tumours was not related to adaptation to tissue
culture since there was no significant difference in
enz6me activity between tumours passaged in
animals and those maintained in vitro. Also the
enzyme activity in a normal human epithelial foetal
lung cell line growing a tissue culture was much
higher than any of the tumour cell lines.
The activity of the enzyme measured in the
direction of acetoacetate synthesis was about 9x
higher than in the direction of acetoacetyl-CoA
Table II Activity of 3-oxo acid CoA transferase
Relative
Activity activity
smolmin-1mg-1 (% ofheart)
Tissue protein+s.e. (n=3) value
Normal
Heart 12.5+0.6 100
Kidney 7.1 +0.5 57
Lymphocytes 6.5+0.5 52
Bladder 4.0+0.5 32
Brain 2.6+0.3 21
Intestine 2.4+0.2 19
L132 1.25+0.05 10
Liver 0.1+0.04 0.8
TImours
M5076 0.65±0.1 5.0
EJ 0.5+0.06 4.0
TLX5 0.4+0.004 3.0
MB 0.4±0.03 3.0
P388 0.3+0.04 2.8
PC6 0.2+0.07 1.8
L1210 0.16+0.06 1.3
W256 0.1 +0.05 0.8
K562 0.01+0.005 0.1
RT112 0 0
formation as has also been observed in rat tissues
(Fenselau & Wallis 1974). In comparison with
normal bladder and lymphocytes the level of the
enzyme in each of the tumours was more
comparable with that of normal liver, i.e. enzyme
activity was virtually absent. This suggests that
acetoacetate may not be utilized as a metabolic
substrate by tumours.
Activity ofacetoacetyl-CoA thiolase in mouse tissues
The distribution of acetoacetyl-CoA thiolase in
normal tissues was similar to that previously
reported (Middleton, 1973) with high levels in heart
and liver and somewhat lower levels in brain (Table
III). In contrast the activity of the enzyme in all
of the tumours was equal to or lower than that of
brain. The presence of thiolase activity in liver and
extrahepatic tumours in contrast with the absence
of 3-oxo acid CoA-transferase probably reflects the
role of the thiolase in processes other than ketone-
body utilization (fatty acid oxidation and
cholesterol synthesis). The activity of the thiolase in
all tissues examined was much higher than that of
the transferase, as previously reported (Fenselau &
Wallis, 1974).
Utilization of 3-hydroxybutyrate by tumour cells in
vitro
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Table III Activity of acetoacetyl-CoA thiolase
Relative
Activity activity
molmin-1 mg-1 (% ofheart)
Tissue protein+ s.e. (n 3) value
Normal
Heart 71 +5 100
Liver 79 +6 111
Kidney 49 +4 69
Intestine 26 +3 37
L132 20 +2 28
Brain 18 +2 25
Bladder 11 +3 15
Lymphocytes 4 +1 6
Tumour
EJ 23 +0.9 32
K562 13.5+2 19
RT112 12.5+0.9 18
TLX5 10 +1 14
L1210 9 +0.5 13
PC6 4 +0.3 6
W256 3.5+0.2 5
MB 1.5+0.2 2
M5076 1.3+0.09 2
P388 0 0
tumours of peripheral tissues suggests that they
might be expected to be incapable of utilizing
ketone bodies as a metabolic substrate. The in vitro
utilization of 3-hydroxybutyrate by 4 tumour cell
lines is shown in Table IV. In no cell line was there a
significant fall in the level of substrate over a 6-day
period. Magee et al. (1979) have shown no
utilization of D-3-hydroxybutyrate by transformed
lymphoblasts at concentrations up to 40mM. At
Table IV Utilization of 3-hydroxybutyrate by tumour
cells in vitro
Day
1 2 3 6
3-HydroxybutyratemM
Control 1.11 1.13 1.07 0.86
TLX5 1.14 1.12 0.98
K562 0.98 1.18 1.04 0.79
Day
1 3 4 7
Control 0.99 0.99 0.99 0.98
EJ 1.24 1.14 1.08 1.02
MB 1.26 1.00 0.99 0.70
Tumour cells were incubated in Dulbecco's M.E.M.
containing 1 gl-1 of glucose and supplemented with 2mM
sodium DL-3-hydroxybutyrate. Controls contained no
tumour cells.
the concentration employed 3-hydroxybutyrate had
no effect on the growth rate of the cell lines.
Discussion
Ketone-bodies serve as an important metabolic fuel
for peripheral tissues during prolonged starvation.
Utilization of 3-hydroxybutyrate and acetoacetate
by the brain under such conditions reduces the
requirement for glucose (Owen et al., 1967). This
leads to a decrease in gluconeogenesis from alanine
and lactate in the liver, which is probably due to a
decreased protein degradation in skeletal muscle.
Infusion of ketone-bodies into humans results in a
specific decline in plasma alanine comparable with
that observed during starvation (Sherwin et al.,
1975). This suggests that ketone-bodies play a
direct role in preventing protein catabolism during
starvation, possibly due to their inhibitory action
on branched-chain amino acid oxidation (Buse et
al., 1972). In addition ketone-bodies can inhibit
lipolysis in adipose tissue either directly, or
indirectly via stimulation of insulin secretion
(Hawkins et al., 1971), thus also reducing the
availability of glycerol for gluconeogenesis.
The inability of any of the tumours or extra-
hepatic tissues investigated to utilize ketone-bodies
suggests a therapeutic strategy for selective nutrient
starvation of these tumours. Infusion of 3-
hydroxybutyrate into cancer patients on a low
carbohydrate diet should counteract the breakdown
of muscle and adipose tissue and act as an energy
source for peripheral tissues reducing the
requirement for glucose. Precursors for
gluconeogenesis (other than lactate) would also
be reduced. The tumour-induced lactate recycling
may also be decreased by inhibiting
phosphoenolpyruvate carboxykinase a key enzyme
in gluconeogenesis (Gold, 1978). Tumours,
especially those exhibiting moderate to severe
hypoxia might be expected to utilize glucose
primarily as an energy source (Demetrakopoulos et
al., 1978) and would also be unable to utilize the
infused ketone-bodies. Tumour growth should
therefore be inhibited by a shortage of essential
metabolic fuels.
Some support for this hypothesis comes from a
study by Magee et al. (1979) who showed that D-3-
hydroxybutyrate caused a reversible, non toxic,
inhibition of tumour cell growth in vitro, while
dietary-induced ketosis reduced the number of B16
melanoma deposits in the lungs of C57BL/6 mice
by two-thirds. Also Schaur et al. (1980) have shown
that the continuous administration of physiological
doses of the branched-chain amino acids leucine,
isoleucine and valine to Yoshida sarcoma-bearing
rats caused a, significant increase in survival timeACETOACETATE COENZYME A TRANSFERASE IN TUMOURS 297
and a significant reduction in tumour size after 3
weeks of growth, as well as an increase in the
synthesis of carcass proteins, while it left the
proteolysis rate unchanged. The branched-chain
amino acids and leucine in particular stimulate
protein synthesis and inhibit protein degradation in
muscle (Snell, 1980). Infusion of keto-acids might
be expected to have a greater effect in reducing
tumour size, since unlike the branched chain amino
acids they are not a source of fuel for
gluconeogenesis.
This work has been supported by a grant from the Cancer
Research Campaign.
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